Main Article Content
The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.
Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R. The risk of recurrent venous
thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis
or pulmonary embolism: a prospective cohort study in 1,626 patients. Haematologica 2007;92:199-205.
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic
therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College
of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e419S-94S.
Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy –
III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical
and medical patients. BMJ 1994;308:235-46.
Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet
therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 2002;324:71-
Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, et al. Aspirin for preventing
the recurrence of venous thromboembolism. N Engl J Med 2012;366:1959-67.
Becattini C, Vedovati MC, Ageno W, Dentali F, Agnelli G. Incidence of arterial cardiovascular events
after venous thromboembolism: a systematic review and a meta-analysis. J Thromb Haemost 2010;8:891-
Brighton TA, Eikelboom J, Mann K, Mister R, Gallus A, Ockelford P, et al. Low dose aspirin for preventing
recurrent venous thromboembolism. N Engl J Med 2012;367:1979-87.